FDA Approved: VIVIMUSTA — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved VIVIMUSTA (bendamustine hydrochloride) from Azurity Pharmaceuticals under Original Application NDA212209.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Multiple Myeloma
• Small Lymphocytic Lymphoma

Drugs mentioned

• VIVIMUSTA (BENDAMUSTINE HYDROCHLORIDE)

Snippet

ORIG AP for VIVIMUSTA (BENDAMUSTINE HYDROCHLORIDE)